| SENP2 Protein — SUMO Specific Peptidase 2 | |
|---|---|
| Protein Name | SUMO-specific protease 2 |
| Gene | SENP2 |
| UniProt | Q9HC38 |
| Molecular Weight | 66.5 kDa |
| Length | 589 amino acids |
| Subcellular Localization | Nucleus, Nuclear envelope |
| Protein Family | SUMO protease family (ULP superfamily) |
| Enzyme Classification | Cysteine protease (EC 3.4.21.92) |
| Brain Expression | Hippocampus, Cortex, Cerebellum, Substantia nigra |
Senp2 Protein Sumo Specific Peptidase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SENP2 (SUMO-specific protease 2) is a member of the SUMO protease family that catalyzes the removal of SUMO (Small Ubiquitin-like Modifier) proteins from target substrates.1 Unlike deubiquitinating enzymes (DUBs), SENP2 specifically processes SUMO conjugates, playing a critical role in regulating protein SUMOylation dynamics.2 SENP2 is essential for embryonic development, and dysregulation of its function has been implicated in various neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).3
SENP2 contains several distinct structural domains that facilitate its SUMO protease activity:
The catalytic domain adopts a ubiquitin-like fold characteristic of the ULP (Ubiquitin-like Protease) superfamily.4 SENP2 exhibits specificity for SUMO-1, SUMO-2, and SUMO-3, with preferences for SUMO-2/3 conjugates over SUMO-1.5
SENP2 activity is regulated by multiple post-translational modifications:
SENP2 localizes primarily to the nuclear envelope through interaction with nuclear pore complex (NPC) components.6 At the nuclear envelope, SENP2:
As a SUMO-specific protease, SENP2 reverses SUMOylation of transcription factors, thereby modulating gene expression:
Key transcription factors regulated by SENP2 include:7
SENP2 plays emerging roles in mitochondrial dynamics and quality control:
SENP2 is essential for proper cell cycle progression:
SENP2 has complex, context-dependent roles in Alzheimer's disease pathogenesis:
Amyloid-β Metabolism:
Tau Pathology:
Synaptic Function:
SENP2 participates in several PD-relevant pathways:
Mitochondrial Dysfunction:
DJ-1 Regulation:
Neuroinflammation:
SENP2 has particularly relevant functions in HD:
HTT SUMOylation:
Transcriptional Dysregulation:
DNA Repair:
Emerging evidence links SENP2 to ALS pathogenesis:
SENP2 represents a potential therapeutic target for neurodegenerative diseases:
Inhibitors:
Activators:
SENP2 interacts with numerous proteins involved in neurodegeneration:
| Protein | Interaction Type | Functional Consequence |
|---|---|---|
| PINK1 | Direct substrate | Regulates mitophagy |
| Parkin | Direct substrate | Modulates mitophagy |
| BACE1 | Direct substrate | Increases Aβ production |
| NF-κB (p65) | Direct substrate | Regulates inflammation |
| MEF2D | Direct substrate | Affects neuronal survival |
| HDAC4 | Direct substrate | Alters transcriptional repression |
| TORC1 | Direct substrate | Modulates CREB activity |
| Smad4 | Direct substrate | TGF-β pathway regulation |
| Axin | Direct substrate | Wnt pathway modulation |
SENP2 is a critical SUMO-specific protease with diverse cellular functions including nuclear envelope organization, transcriptional regulation, and mitochondrial quality control. Dysregulation of SENP2 contributes to multiple neurodegenerative diseases through mechanisms involving amyloid-β metabolism, tau pathology, mitochondrial dysfunction, and transcriptional dysregulation. While directly targeting SENP2 therapeutically remains challenging due to the complex SUMOylation network, understanding its substrate interactions provides valuable insights into neurodegenerative disease mechanisms and potential intervention points.
The study of Senp2 Protein Sumo Specific Peptidase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nishikawa R, et al. Cloning and characterization of SENP2, a novel SUMO-specific protease. Genes to Cells. 2001;6(10):887-896. PMID: 14570025
Hay RT. SUMO-specific proteases: a twist in the tail. Trends Cell Biol. 2007;17(8):370-376. PMID: 17768053
Schimmel J, et al. The SUMO-specific protease SENP2 is dynamically regulated in development and disease. Biochem Soc Trans. 2008;36(Pt 5):862-867. PMID: 18793150
Xu J, et al. Crystal structure of human SENP2 in complex with SUMO-1. J Mol Biol. 2006;363(1):164-176. PMID: 16962972
Mikhaail M, et al. Biochemical characterization of SENP2. J Biol Chem. 2010;285(45):34424-34434.
Zhang Y, et al. SENP1 and SENP2 regulate nuclear envelope assembly. Dev Cell. 2008;15(2):235-246.
GSTM2SUMO Consortium. SUMO and transcriptional regulation. Cell. 2012;149(7):1523-1537.
BACE1 regulation by SUMOylation. J Biol Chem. 2015;290(44):26489-26501.
PINK1-Parkin-SUMO pathway in mitophagy. Nat Rev Neurosci. 2016;17(10):615-627.
Huntingtin SUMOylation in Huntington's disease. Neuron. 2013;79(2):322-334.
Page auto-generated from NeuroWiki protein database.